Claude

Web Research: Everest Industries Ltd (EVERESTIND)

The Bottom Line from the Web

Everest Industries is in the midst of a triple crisis that financial filings alone do not fully convey: a sharp Q3 FY26 revenue decline of 26.8% YoY with widening losses, a leadership transition (new MD Hemant Khurana replaced Rajesh Joshi in September 2025), and a stock in freefall – down 55% from its 52-week high to hit fresh lows of Rs 284.90 in March 2026. The single most important web finding is that the company's credit ratings have been downgraded, with the rating agency citing operating margins collapsed to just 1.7% in FY2025, the new Mysore plant still struggling to ramp up, and the Ananthapuram steel building facility deferred to FY27. Meanwhile, the National Green Tribunal's October 2025 order on asbestos – stopping short of a ban but mandating a gradual phase-out from schools – adds regulatory overhang to the core roofing business.

What Matters Most

1. Q3 FY26 Financial Deterioration – Revenue Plunges 27%, Losses Widen 167%

Source: Whalesbook, February 6, 2026. This is not merely a seasonal dip – it represents structural margin pressure from lower asbestos roofing volumes and continued ramp-up costs at the Mysore plant.

2. Credit Rating Downgrade – Margins Collapsed to 1.7%

Source: Credit rating report referenced across Alpha Spread and rating databases. The Altman Z-score of 2.43 ranks Everest 5th out of 7 competitors, placing it in the "grey zone" – not immediately distressed but financially fragile.

3. Leadership Transition – Rajesh Joshi Out, Hemant Khurana In

Source: Economic Times, Moneycontrol, Business Standard. Khurana's background at Saint-Gobain India (where he served as Executive Director) brings building materials expertise. However, Joshi's departure after a relatively short tenure during the company's weakest performance period raises questions about internal dynamics.

4. Steel Building Facility Deferred to FY27 – Growth Optionality Delayed

Source: ScanX News, April 2, 2026. The deferral suggests either capital conservation under financial stress or demand uncertainty in the PEB segment. This removes near-term capacity-led growth optionality in the higher-margin steel buildings business.

5. Asbestos Regulatory Risk Elevated – NGT Orders Gradual Phase-Out

Source: Indian Express, October 31, 2025. While not an outright ban, this represents the strongest regulatory signal yet against asbestos. India still allows chrysotile asbestos (which is 85% imported from Russia), but the direction of travel is unmistakably toward restriction. Everest's roofing segment – still the majority of revenue – faces long-term existential risk.

6. Key Personnel Turnover in Control Functions

Source: ScanX News, March 2026. The rapid succession and appointment of a strategy head to the CRO position (rather than a dedicated risk professional) warrants monitoring.

7. Stock Hits 52-Week Low of Rs 284.90 in March 2026

The stock declined to Rs 284.90 on March 30, 2026, a 62% collapse from the September 2025 high of Rs 750. The current price of Rs 335 represents a market capitalization of just Rs 528 crore – micro-cap territory for a 92-year-old company with Rs 1,500+ crore in revenue.

Source: MarketsMojo, CNBC.

8. Promoter Holding Stable at 50.15% – Sekhsaria Family Control Intact

Promoter holding remained unchanged at 50.15% as of June 2025. The Sekhsaria family (connected to the Ambuja Cement founders through NSFO – Narotam Sekhsaria Family Office) controls the company through Falak Investment Pvt Ltd and Madhurima International. No evidence of promoter share pledge was found in web searches, which is a modest positive.

Source: BusinessToday, Moneycontrol.

9. India Fibre Cement Market Growing at 8-9% CAGR Despite Company Weakness

Source: Research and Markets, Actual Market Research. Everest's revenue decline in a growing market suggests market share erosion to competitors like Ramco Industries, Visaka Industries, and HIL.

10. Chrysotile Import Prices Declining – Potential Margin Tailwind

Chrysotile asbestos import prices fell 7.35% in early 2025, settling at USD 0.63K/ton. India imported USD 102.9 million of asbestos from Russia in 2024. Russia remains the leading source with a 44.9% share.

Source: UN COMTRADE via TradingEconomics, November 2025 research report. If sustained, lower input costs could provide relief to roofing margins in H2 FY26.

Recent News Timeline

What the Specialists Asked

Insider Spotlight

The Sekhsaria family (NSFO – Narotam Sekhsaria Family Office) controls Everest through Falak Investment Pvt Ltd and Madhurima International. The family acquired control of Everest Industries in 2005, departing from their established practice of jointly managing cement businesses (Ambuja Cement). Padmini Sekhsaria is Chairperson of Madhurima International. Promoter holding has been stable at 50.15%.

The MD/CEO position has seen turnover: Rajesh Joshi was re-appointed in early 2025 and resigned months later. His predecessor's tenure details were not found in web research. The pattern of short MD tenures at a company undergoing strategic transformation is a governance concern worth monitoring.

Industry Context

Key industry dynamics:

The India fibre cement market is structurally growing at 8-9% CAGR, driven by rural and urban housing demand. Cement demand overall is expected to grow at 7-8% CAGR. However, Everest's revenue decline in a growing market indicates company-specific issues rather than industry headwinds.

Competitive positioning: Everest's major competitors are Visaka Industries, Ramco Industries (Bansal Roofing), Sahyadri Industries, BirlaNu, and Kanoria. Ramco earns meaningfully higher margins (approximately 11% OPM vs Everest's approximately 2%) on similar scale, suggesting Everest's margin problem is operational rather than industry-wide. International entrants like James Hardie are expanding globally but Everest retains a domestic cost advantage.

Asbestos regulatory trajectory: India is the world's largest importer of chrysotile asbestos, with 85% coming from Russia. While the government has resisted outright bans, the NGT's October 2025 order marks an inflection point. Over 70 countries have banned asbestos entirely. India's position – banning mining but allowing imports and use – is increasingly untenable as health evidence mounts. For Everest, this creates urgency to accelerate the transition from asbestos roofing to non-asbestos boards and panels, which is exactly the Mysore plant strategy. The speed of that transition is the central investment question.